AMEX · Price History

Apimeds Pharmaceuticals US, Inc. (APUS) Stock Price History & Returns

$1.95 AMEX: APUS Market Cap $2.94M

Price history through Nov 17, 2026 · Source: Yahoo Finance (adjusted closes) (methodology)

How Apimeds Pharmaceuticals US, Inc. (APUS) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

The share price of $1.95 sits 1% of the way up a 52-week range of $1.51 to $59.70; 96.7% below the 52-week high; below its 50-day moving average of $3.43; below its 200-day average of $10.03; a beta of 0.15 means it has historically moved less than the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months-49.0%
6 months-85.3%
1 year-93.6%

Year by year

0 of 1 years closed higher than the year before. Closes are the last observation in each calendar year.

YearCloseChange
2026$1.95-88.1%

Monthly closing prices

The last 19 months, newest first. 8 of 18 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
November 2026$1.95-35.2%
October 2026$3.01-39.8%
September 2026$5.00+28.9%
August 2026$3.88-24.7%
July 2026$5.15-42.8%
June 2026$9.00-36.2%
May 2026$14.10-25.0%
April 2026$18.80+5.1%
March 2026$17.89+31.5%
February 2026$13.60-26.5%
January 2026$18.50+12.8%
December 2025$16.40-43.4%
November 2025$29.00+32.4%
October 2025$21.90+23.0%
September 2025$17.80-2.7%
August 2025$18.30+5.2%
July 2025$17.40-1.1%
June 2025$17.60+0.6%
May 2025$17.50—

Apimeds Pharmaceuticals US, Inc. (APUS) price history — frequently asked questions

How has Apimeds Pharmaceuticals US, Inc. performed over the last year?

Apimeds Pharmaceuticals US, Inc. (APUS) has fallen 93.6% over the last twelve months, measured on price alone.

What is Apimeds Pharmaceuticals US, Inc.'s five-year return?

Over five years the APUS share price has gained 0.0%, excluding dividends.

What is Apimeds Pharmaceuticals US, Inc.'s 52-week range?

Over the last year Apimeds Pharmaceuticals US, Inc. (APUS) has traded between $1.51 and $59.70.

Price returns of other Biotechnology stocks

VRTX 1-year +22.4%REGN 1-year +38.2%MRNA 1-year +740.3%RVMD 1-year +137.0%ROIV 1-year +92.3%INSM 1-year -36.3%UTHR 1-year +27.9%INCY 1-year +14.8%ALNY 1-year -63.6%ASND 1-year +33.4%All Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.